Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention.

Mangiacapra F, Bressi E, Di Gioia G, Pellicano M, Di Serafino L, Peace AJ, Bartunek J, Morisco C, Wijns W, De Bruyne B, Barbato E.

Int J Cardiol. 2019 Dec 24. pii: S0167-5273(19)35015-6. doi: 10.1016/j.ijcard.2019.12.042. [Epub ahead of print]

PMID:
31926642
2.

Impact of increased venous pressure on kidney function and mortality in cardiovascular patients with preserved ejection fraction.

Milkas A, Tsioufis K, Koliastasis L, Tsiamis E, Tousoulis D, Bartunek J, Vanderheyden M.

Curr Med Res Opin. 2020 Jan 6:1-7. doi: 10.1080/03007995.2019.1708286. [Epub ahead of print]

PMID:
31868029
3.

Peripheral Blood RNA Levels of QSOX1 and PLBD1 Are New Independent Predictors of Left Ventricular Dysfunction After Acute Myocardial Infarction.

Vanhaverbeke M, Vausort M, Veltman D, Zhang L, Wu M, Laenen G, Gillijns H, Moreau Y, Bartunek J, Van De Werf F, Devaux Y, Janssens S, Sinnaeve PR; EU-CardioRNA COST Action CA17129.

Circ Genom Precis Med. 2019 Dec;12(12):e002656. doi: 10.1161/CIRCGEN.119.002656. Epub 2019 Nov 22.

PMID:
31756302
4.

Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis.

Collet C, Sonck J, Vandeloo B, Mizukami T, Roosens B, Lochy S, Argacha JF, Schoors D, Colaiori I, Di Gioia G, Kodeboina M, Suzuki H, Van 't Veer M, Bartunek J, Barbato E, Cosyns B, De Bruyne B.

J Am Coll Cardiol. 2019 Oct 8;74(14):1772-1784. doi: 10.1016/j.jacc.2019.07.072.

PMID:
31582137
5.

Silent coronary artery disease in asymptomatic patients with severe aortic stenosis and normal exercise testing.

Banovic M, Iung B, Brkovic V, Nikolic S, Mitrovic P, Van Camp G, Penicka M, Simic D, Kockova R, Aleksandric S, Asanin M, Nedeljkovic I, Popovic D, Putnik S, Jaukovic M, Bartunek J.

Coron Artery Dis. 2020 Mar;31(2):166-173. doi: 10.1097/MCA.0000000000000801.

PMID:
31577622
6.

Addressing the Treatment Dilemma in Asymptomatic Aortic Stenosis: The AVATAR Trial.

Banovic M, Iung B, Putnik S, Nikolic S, Penicka M, Deja M, Bartunek J.

JACC Cardiovasc Imaging. 2019 Sep;12(9):1896-1897. doi: 10.1016/j.jcmg.2019.07.012. No abstract available.

PMID:
31488255
7.

Treatment of Diuretic Resistance with a Novel Percutaneous Blood Flow Regulator: Concept and Initial Experience.

Dierckx R, Vanderheyden M, Heggermont W, Goethals M, Verstreken S, Bartunek J.

J Card Fail. 2019 Nov;25(11):932-934. doi: 10.1016/j.cardfail.2019.08.017. Epub 2019 Aug 30.

PMID:
31476373
8.

Fractional flow reserve in patients with reduced ejection fraction.

Di Gioia G, De Bruyne B, Pellicano M, Bartunek J, Colaiori I, Fiordelisi A, Canciello G, Xaplanteris P, Fournier S, Katbeh A, Franco D, Kodeboina M, Morisco C, Van Praet F, Casselman F, Degrieck I, Stockman B, Vanderheyden M, Barbato E.

Eur Heart J. 2019 Aug 16. pii: ehz571. doi: 10.1093/eurheartj/ehz571. [Epub ahead of print]

PMID:
31419282
9.

Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy.

Yamada S, Arrell DK, Rosenow CS, Bartunek J, Behfar A, Terzic A.

Stem Cells Transl Med. 2020 Jan;9(1):74-79. doi: 10.1002/sctm.19-0149. Epub 2019 Aug 2.

10.

Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus.

Colaiori I, Izzo R, Barbato E, Franco D, Di Gioia G, Rapacciuolo A, Bartunek J, Mancusi C, Losi MA, Strisciuglio T, Manzi MV, de Simone G, Trimarco B, Morisco C.

J Clin Med. 2019 Jul 21;8(7). pii: E1069. doi: 10.3390/jcm8071069.

11.

The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction.

Paitazoglou C, Özdemir R, Pfister R, Bergmann MW, Bartunek J, Kilic T, Lauten A, Schmeisser A, Zoghi M, Anker S, Sievert H, Mahfoud F.

EuroIntervention. 2019 Aug 29;15(5):403-410. doi: 10.4244/EIJ-D-19-00342.

12.

Cardiac Resynchronization Therapy Optimization: A Comprehensive Approach.

Katbeh A, Van Camp G, Barbato E, Galderisi M, Trimarco B, Bartunek J, Vanderheyden M, Penicka M.

Cardiology. 2019;142(2):116-128. doi: 10.1159/000499192. Epub 2019 May 22. Review.

PMID:
31117077
13.

PROcedure related microvascular ACTIVation in long lEsions treated with bioresorbable vascular scaffold versus everolimus-eluting stent implantation (PROACTIVE trial).

Pellicano M, Di Gioia G, Ciccarelli G, Xaplanteris P, Delrue L, Toth GG, Van Durme F, Heyse A, Wyffels E, Vanderheyden M, Bartunek J, De Bruyne B, Barbato E.

EuroIntervention. 2019 May 14. pii: EIJ-D-18-01138. doi: 10.4244/EIJ-D-18-01138. [Epub ahead of print]

14.

Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.

Frigoli E, Smits P, Vranckx P, Ozaki Y, Tijssen J, Jüni P, Morice MC, Onuma Y, Windecker S, Frenk A, Spaulding C, Chevalier B, Barbato E, Tonino P, Hildick-Smith D, Roffi M, Kornowski R, Schultz C, Lesiak M, Iñiguez A, Colombo A, Alasnag M, Mullasari A, James S, Stankovic G, Ong PJL, Rodriguez AE, Mahfoud F, Bartunek J, Moschovitis A, Laanmets P, Leonardi S, Heg D, Sunnåker M, Valgimigli M.

Am Heart J. 2019 Mar;209:97-105. doi: 10.1016/j.ahj.2018.10.009. Epub 2018 Nov 22.

15.

A Novel Wireless Left Atrial Pressure Monitoring System for Patients with Heart Failure, First Ex-Vivo and Animal Experience.

Perl L, Soifer E, Bartunek J, Erdheim D, Köhler F, Abraham WT, Meerkin D.

J Cardiovasc Transl Res. 2019 Aug;12(4):290-298. doi: 10.1007/s12265-018-9856-3. Epub 2019 Jan 2.

PMID:
30604310
16.

Natriuretic Peptide Processing in Patients with and Without Left Ventricular Dysfunction.

Verstreken S, Delrue L, Goethals M, Bartunek J, Vanderheyden M.

Int Heart J. 2019 Jan 25;60(1):115-120. doi: 10.1536/ihj.18-012. Epub 2018 Dec 5.

17.

Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel.

Mangiacapra F, Pellicano M, Di Serafino L, Bressi E, Peace AJ, Di Gioia G, Morisco C, Bartunek J, Wijns W, Bruyne B, Barbato E.

Atherosclerosis. 2018 Nov;278:23-28. doi: 10.1016/j.atherosclerosis.2018.08.044. Epub 2018 Aug 30.

PMID:
30236867
18.

One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.

Shah SJ, Feldman T, Ricciardi MJ, Kahwash R, Lilly S, Litwin S, Nielsen CD, van der Harst P, Hoendermis E, Penicka M, Bartunek J, Fail PS, Kaye DM, Walton A, Petrie MC, Walker N, Basuray A, Yakubov S, Hummel SL, Chetcuti S, Forde-McLean R, Herrmann HC, Burkhoff D, Massaro JM, Cleland JGF, Mauri L.

JAMA Cardiol. 2018 Oct 1;3(10):968-977. doi: 10.1001/jamacardio.2018.2936.

19.

Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery.

Fournier S, Toth GG, De Bruyne B, Johnson NP, Ciccarelli G, Xaplanteris P, Milkas A, Strisciuglio T, Bartunek J, Vanderheyden M, Wyffels E, Casselman F, Van Praet F, Stockman B, Degrieck I, Barbato E.

Circ Cardiovasc Interv. 2018 Jun;11(6):e006368. doi: 10.1161/CIRCINTERVENTIONS.117.006368.

PMID:
29848611
20.

Clinical Experience With Regenerative Therapy in Heart Failure: Advancing Care With Cardiopoietic Stem Cell Interventions.

Bartunek J, Terzic A, Behfar A, Wijns W.

Circ Res. 2018 May 11;122(10):1344-1346. doi: 10.1161/CIRCRESAHA.118.312753. Review. No abstract available.

21.

Macrophage migration inhibitory factor (MIF) is associated with degree of collateralization in patients with totally occluded coronary arteries.

Di Serafino L, Bartunek J, Heyndrickx G, Dierickx K, Scognamiglio G, Tesorio T, De Bruyne B, Trimarco B, Wijns W, Barbato E.

Int J Cardiol. 2018 Jul 1;262:14-19. doi: 10.1016/j.ijcard.2018.03.094. Epub 2018 Mar 21.

PMID:
29602581
22.

First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery.

Sherman W, Bartunek J, Dolatabadi D, Sanz-Ruiz R, Beleslin B, Wojakowski W, Heyndrickx G, Kimpalou JZ, Waldman SA, Laarman GJ, Seron A, Behfar A, Latere JP, Terzic A, Wijns W; CHART Program.

JACC Cardiovasc Interv. 2018 Feb 26;11(4):412-414. doi: 10.1016/j.jcin.2017.10.036. No abstract available.

23.

Resolving Apparent Inconsistencies Between Area, Flow, and Gradient Measurements in Patients With Aortic Valve Stenosis and Preserved Left Ventricular Ejection Fraction.

Mo Y, Penicka M, Di Gioia G, Barbato E, Ondrus T, Vanderheyden M, De Bruyne B, Bartunek J, Van Camp G.

Am J Cardiol. 2018 Mar 15;121(6):751-757. doi: 10.1016/j.amjcard.2017.11.047. Epub 2017 Dec 25.

PMID:
29395002
24.

Automatic estimation of a scale resolution in forensic images.

Gertsovich I, Nilsson M, Bartůněk JS, Claesson I.

Forensic Sci Int. 2018 Feb;283:58-71. doi: 10.1016/j.forsciint.2017.12.007. Epub 2017 Dec 11.

PMID:
29274623
25.

The Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A protocol update.

Banovic M, Iung B, Bartunek J, Penicka M, Vanderheyden M, Casselman F, van Camp G, Nikolic S, Putnik S.

Am Heart J. 2018 Jan;195:153-154. doi: 10.1016/j.ahj.2017.10.005. Epub 2017 Oct 14. No abstract available.

PMID:
29224644
26.

Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy.

Ciccarelli G, Barbato E, Toth GG, Gahl B, Xaplanteris P, Fournier S, Milkas A, Bartunek J, Vanderheyden M, Pijls N, Tonino P, Fearon WF, Jüni P, De Bruyne B.

Circulation. 2018 Apr 3;137(14):1475-1485. doi: 10.1161/CIRCULATIONAHA.117.028782. Epub 2017 Nov 21. Erratum in: Circulation. 2018 May 29;137(22):e820.

27.

Pitfalls in coronary artery stenosis assessment in takotsubo syndrome: The role of microvascular dysfunction.

Heyse A, Milkas A, Van Durme F, Barbato E, Lazaros G, Vanderheyden M, Bartunek J.

Hellenic J Cardiol. 2018 Sep - Oct;59(5):290-292. doi: 10.1016/j.hjc.2017.10.003. Epub 2017 Nov 13. No abstract available.

28.

Aortic valve replacement improves survival in severe aortic stenosis with gradient-area mismatch.

Mo Y, Van Camp G, Di Gioia G, Barbato E, Ondrus T, Casselman F, Vanderheyden M, De Bruyne B, Bartunek J, Penicka M.

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):569-575. doi: 10.1093/ejcts/ezx362.

PMID:
29040507
29.

The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial.

Mathur A, Arnold R, Assmus B, Bartunek J, Belmans A, Bönig H, Crea F, Dimmeler S, Dowlut S, Fernández-Avilés F, Galiñanes M, Garcia-Dorado D, Hartikainen J, Hill J, Hogardt-Noll A, Homsy C, Janssens S, Kala P, Kastrup J, Martin J, Menasche P, Miklik R, Mozid A, San Román JA, Sanz-Ruiz R, Tendera M, Wojakowski W, Ylä-Herttuala S, Zeiher A.

Eur J Heart Fail. 2017 Nov;19(11):1545-1550. doi: 10.1002/ejhf.829. Epub 2017 Sep 25.

30.

Intracoronary autologous bone marrow cell transfer after acute myocardial infarction: abort and refocus.

Bartunek J, Wojakowski W.

Eur Heart J. 2017 Oct 14;38(39):2944-2947. doi: 10.1093/eurheartj/ehx300. No abstract available.

PMID:
28637251
31.

Minimally invasive mitral valve annuloplasty confers a long-term survival benefit compared with state-of-the-art treatment in heart failure with functional mitral regurgitation.

Penicka M, Kotrc M, Ondrus T, Mo Y, Casselman F, Vanderheyden M, Van Camp G, Van Praet F, Bartunek J.

Int J Cardiol. 2017 Oct 1;244:235-241. doi: 10.1016/j.ijcard.2017.06.029. Epub 2017 Jun 8.

PMID:
28624330
32.

Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study.

Teerlink JR, Metra M, Filippatos GS, Davison BA, Bartunek J, Terzic A, Gersh BJ, Povsic TJ, Henry TD, Alexandre B, Homsy C, Edwards C, Seron A, Wijns W, Cotter G; CHART Investigators.

Eur J Heart Fail. 2017 Nov;19(11):1520-1529. doi: 10.1002/ejhf.898. Epub 2017 May 31.

33.

Platelet reactivity in patients carrying the e-NOS G894T polymorphism after a loading dose of aspirin plus clopidogrel.

Strisciuglio T, Di Gioia G, Mangiacapra F, De Biase C, Delrue L, Pellicano M, Bartunek J, Vanderheyden M, Izzo R, Trimarco B, Wijns W, Barbato E.

Thromb Res. 2017 Mar;151:72-73. doi: 10.1016/j.thromres.2017.01.011. Epub 2017 Jan 27. No abstract available.

PMID:
28160671
34.

Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.

Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, Merkely B, Musialek P, Wojakowski W, Andreka P, Horvath IG, Katz A, Dolatabadi D, El Nakadi B, Arandjelovic A, Edes I, Seferovic PM, Obradovic S, Vanderheyden M, Jagic N, Petrov I, Atar S, Halabi M, Gelev VL, Shochat MK, Kasprzak JD, Sanz-Ruiz R, Heyndrickx GR, Nyolczas N, Legrand V, Guédès A, Heyse A, Moccetti T, Fernandez-Aviles F, Jimenez-Quevedo P, Bayes-Genis A, Hernandez-Garcia JM, Ribichini F, Gruchala M, Waldman SA, Teerlink JR, Gersh BJ, Povsic TJ, Henry TD, Metra M, Hajjar RJ, Tendera M, Behfar A, Alexandre B, Seron A, Stough WG, Sherman W, Cotter G, Wijns W; CHART Program.

Eur Heart J. 2017 Mar 1;38(9):648-660. doi: 10.1093/eurheartj/ehw543.

35.

Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long-Term Outcome.

Ciccarelli G, Barbato E, Golino M, Cimmino G, Bartunek J, Di Serafino L, Di Girolamo D, De Bruyne B, Wijns W, Golino P.

J Interv Cardiol. 2017 Feb;30(1):5-15. doi: 10.1111/joic.12360. Epub 2016 Dec 7.

PMID:
27925310
36.

Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experience.

Heggermont WA, Goethals M, Dierckx R, Verstreken S, Bartunek J, Vanderheyden M.

Heart Fail Rev. 2016 Nov;21(6):699-701. Review.

PMID:
27620301
37.

Percutaneous Treatment of Aortic Valve Disease: Contemporary Overview and Future Trends.

Banovic M, Bartunek J, Nikolic SD, Vukcevic V, Aleksandric S, Iung B.

Curr Pharm Des. 2017;23(31):4687-4695. doi: 10.2174/1381612822666161018162022. Review.

PMID:
27774907
38.

Plaque protrusion compromising bioresorbable coronary scaffold patency.

Floré V, Pellicano M, Adjedj J, Ferrara A, Van Der Steen K, Bartunek J.

EuroIntervention. 2016 Sep 18;12(7):873. doi: 10.4244/EIJV12I7A142. No abstract available.

39.

Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.

Vandenwijngaert S, Swinnen M, Walravens AS, Beerens M, Gillijns H, Caluwé E, Tainsh RE, Nathan DI, Allen K, Brouckaert P, Bartunek J, Scherrer-Crosbie M, Bloch KD, Bloch DB, Janssens SP, Buys ES.

Antioxid Redox Signal. 2017 Feb 1;26(4):153-164. doi: 10.1089/ars.2015.6542. Epub 2016 Sep 8.

40.

Response: Asymptomatic severe aortic stenosis: Cardiopulmonary exercise testing in "the world of AVATAR".

Banovic M, Iung B, Bartunek J, Penicka M, van Camp G, Nikolic S, Putnik S.

Am Heart J. 2016 Aug;178:e3-4. doi: 10.1016/j.ahj.2016.06.013. Epub 2016 Jun 25. No abstract available.

PMID:
27502872
41.

Direct implantation of rapamycin-eluting stents with bioresorbable drug carrier technology utilising the Svelte coronary stent-on-a-wire: the DIRECT II study.

Verheye S, Khattab AA, Carrie D, Stella P, Slagboom T, Bartunek J, Onuma Y, Serruys PW.

EuroIntervention. 2016 Aug 5;12(5):e615-22. doi: 10.4244/EIJV12I5A101.

42.

Myocarditis in Clinical Practice.

Sinagra G, Anzini M, Pereira NL, Bussani R, Finocchiaro G, Bartunek J, Merlo M.

Mayo Clin Proc. 2016 Sep;91(9):1256-66. doi: 10.1016/j.mayocp.2016.05.013. Epub 2016 Jul 31. Review.

PMID:
27489051
43.

Relationship of asymmetric dimethylarginine (ADMA) with extent and functional severity of coronary atherosclerosis.

Mangiacapra F, Conte M, Demartini C, Muller O, Delrue L, Dierickx K, Di Sciascio G, Trimarco B, De Bruyne B, Wijns W, Bartunek J, Barbato E.

Int J Cardiol. 2016 Oct 1;220:629-33. doi: 10.1016/j.ijcard.2016.06.254. Epub 2016 Jun 28.

PMID:
27391005
44.

Effects of Prasugrel Versus Clopidogrel on Coronary Microvascular Function in Patients Undergoing Elective PCI.

Mangiacapra F, Di Gioia G, Pellicano M, Di Serafino L, Bressi E, Peace AJ, Bartunek J, Wijns W, De Bruyne B, Barbato E.

J Am Coll Cardiol. 2016 Jul 12;68(2):235-7. doi: 10.1016/j.jacc.2016.04.039. No abstract available.

45.

Minimally invasive mitral valve repair for functional mitral regurgitation in severe heart failure: MitraClip versus minimally invasive surgical approach.

Ondrus T, Bartunek J, Vanderheyden M, Stockman B, Kotrc M, Van Praet F, Van Camp G, Lecomte P, Mo Y, Penicka M.

Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):784-789. Epub 2016 Jun 29.

PMID:
27357467
46.

Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial.

Banovic M, Iung B, Bartunek J, Asanin M, Beleslin B, Biocina B, Casselman F, da Costa M, Deja M, Gasparovic H, Kala P, Labrousse L, Loncar Z, Marinkovic J, Nedeljkovic I, Nedeljkovic M, Nemec P, Nikolic SD, Pencina M, Penicka M, Ristic A, Sharif F, Van Camp G, Vanderheyden M, Wojakowski W, Putnik S.

Am Heart J. 2016 Apr;174:147-53. doi: 10.1016/j.ahj.2016.02.001. Epub 2016 Feb 9.

PMID:
26995381
47.

Fractional Flow Reserve-Guided Revascularization in Patients With Aortic Stenosis.

Di Gioia G, Pellicano M, Toth GG, Casselman F, Adjedj J, Van Praet F, Ferrara A, Stockman B, Degrieck I, Bartunek J, Trimarco B, Wijns W, De Bruyne B, Barbato E.

Am J Cardiol. 2016 May 1;117(9):1511-5. doi: 10.1016/j.amjcard.2016.02.023. Epub 2016 Feb 18.

PMID:
26976789
48.

Novel device-based interventional strategies for advanced heart failure.

Toth GG, Vanderheyden M, Bartunek J.

Postepy Kardiol Interwencyjnej. 2016;12(1):13-6. doi: 10.5114/pwki.2016.56944. Epub 2016 Feb 11. Review.

49.

Wasted septal work in left ventricular dyssynchrony: a novel principle to predict response to cardiac resynchronization therapy.

Vecera J, Penicka M, Eriksen M, Russell K, Bartunek J, Vanderheyden M, Smiseth OA.

Eur Heart J Cardiovasc Imaging. 2016 Jun;17(6):624-32. doi: 10.1093/ehjci/jew019. Epub 2016 Feb 25.

50.

Impact of Right Atrial Pressure on Fractional Flow Reserve Measurements: Comparison of Fractional Flow Reserve and Myocardial Fractional Flow Reserve in 1,600 Coronary Stenoses.

Toth GG, De Bruyne B, Rusinaru D, Di Gioia G, Bartunek J, Pellicano M, Vanderheyden M, Adjedj J, Wijns W, Pijls NH, Barbato E.

JACC Cardiovasc Interv. 2016 Mar 14;9(5):453-9. doi: 10.1016/j.jcin.2015.11.021. Epub 2016 Feb 17. Erratum in: JACC Cardiovasc Interv. 2016 Oct 24;9(20):2181.

Supplemental Content

Loading ...
Support Center